Although Epstein-Barr virus (EBV) is often found in human tonsils, it remains to be precisely determined in what cells and microenvironment the virus is present. Although generally regarded as a B lymphotropic virus, EBV is associated with non-B-cell tumors, for example, NK/T-cell lymphoma, carcinoma, and leiomyosarcoma. To provide a basis for understanding the origin and biology of EBV-infected non-B cells, the immunophenotype of all EBV-infected cells in reactive human tonsils was determined by subjecting tonsil sections to dual/triple EBER in situ hybridization and immunohistochemistry with monoclonal antibodies to T cells (CD3, CD4, CD8, 
Based upon serologic surveys, more than 90% of adults worldwide have been infected by the Epstein-Barr virus (EBV). 1 Nearly all infection is acquired by oral contact with a person carrying EBV in saliva. 2 Although the exact details of virus transmission in the oral cavity remain unknown, it is likely that initial infection of either oral epithelial cells or tonsillar B cells is followed by a brief period of replication and lifelong persistence in B lymphocytes. 3 In one study, no EBV-infected epithelial cells were identified in tonsils removed during infectious mononucleosis, strongly suggesting that EBV infection of epithelial cells, if it occurs at all, must be a rare event. 4 It has been suggested that B cells might encounter salivary EBV directly through the crypt epithelium, thus bypassing the need for virus transmission from epithelial cell to B lymphocyte. 5 It has been suggested that newly infected tonsil B cells first migrate to germinal centers where they proliferate under the influence of the full complement of latent viral proteins, 6 followed by persistence as long-lived memory B cells with viral gene expression limited to LMP2a. 7 In the present study, formalin-fixed paraffinembedded sections of EBV-positive human tonsils surgically removed for tonsillar enlargement were subjected to combined immunohistochemistry and EBER in situ hybridization (ISH) to localize EBV within various phenotypically defined cell types, including CD3-positive T cells, CD20-positive B cells, PEN5-positive natural killer (NK) cells, CD138-positive plasma cells, and cytokeratin-positive epithelial cells. To characterize EBV gene expression in infected cells, immunohistochemical staining for EBV latent proteins EBNA1, EBNA2, and LMP2a on frozen sections, and the immediateearly protein BZLF1 on paraffin sections was also performed.
Materials and methods

Tonsil Specimens
Fresh frozen tissue from approximately 50 tonsils was first screened by EBNA1 PCR, of which 490% were positive. A randomly chosen subset of 20 was then selected for EBER ISH (on paraffin sections). The age range of the tonsil donors was 5-57 years (mean age 24 years), with a male/female ratio of 1.2 and a 50% white, 30% black, and 20% Hispanic ethnic distribution. While most tonsils tested contained fewer than 10 EBER þ cells per tissue section, after much searching we identified six with 50-150 positive cells per section. These tonsils were selected for dual or triple EBER ISH and immunohistochemistry with a fluorescein-labeled EBER1 oligonucleotide probe, and monoclonal antibodies to T cells (CD3, CD4, CD8, CCR3), B cells (CD20), plasma cells (CD138), NK cells (PEN5), and epithelial cells (pan-cytokeratin). EBV protein expression was detected by frozen section immunohistochemistry with antibodies to latent proteins EBNA1, EBNA2, LMP1, and LMP2a, and by paraffin section immunohistochemistry with antibody to the immediate-early protein BZLF1 (ZEBRA).
EBNA1 PCR
DNA was extracted from fresh frozen tonsil tissue (QIAamp DNA Midi kit, Qiagen, Valencia, CA, USA) and subjected to nested PCR using two sets of nonoverlapping primers to the EBNA1 gene (external: 5 0 -CCTGTAGGGGAAGCCGAT and 5 0 -CAATGGTGTAAGACGACATT, internal: 5 0 -CCAA GAAGGTGGCCCAGA and 5 0 -CCTGCCTCCATCAC CCTG). A 387 bp external PCR product and a 120 bp internal PCR product were obtained. Nested PCR products were detected by chemiluminescent dot blot hybridization with a digoxigenin 3 0 -endlabeled (Roche Diagnostics, Indianapolis, IN, USA) oligonucleotide probe (5 0 -ACGCATGCATCTCCCTGT). 
EBER ISH
Results
Distribution and Morphology of EBV-Infected Tonsil Cells
Nearly 60% of the EBER-positive cells were found within the T-cell-rich interfollicular regions, while 27% were present within the crypt epithelium, and 15% were present within the B-cell-rich germinal centers of secondary follicles ( 
Immunophenotype of EBV-Infected Tonsil Cells
Most (82%) of the EBER-positive tonsil cells very weakly expressed the B-cell marker CD20, while 11% did not clearly express any of the cell lineage markers for B cells, T cells, plasma cells, NK cells, or epithelial cells (Table 1) . In contrast to CD20, only 11% of EBER-positive cells stained with antibody to the B-cell-specific antigen CD79a in the single case tested. Since many of the small cells of indeterminate phenotype had plasmacytoid features, and at least some appeared to express very dim CD20, many of these cells may be plasmacytoid B cells. 
Discussion
EBV infection is very common, with adult seroprevalence rates in excess of 90% worldwide. Following primary infection in the oropharynx, EBV persists in numerous anatomical sites including pharyngeal tonsils, adenoids, lymph nodes, and peripheral blood. In peripheral blood, virus is present in small resting memory B cells with latent gene expression limited to EBER, LMP2a, and perhaps EBNA1. 7 In RT-PCR studies of isolated B cells from persistently infected tonsils, latent virus was found in all B-cell subsets, most commonly in IgD-memory B cells, but including IgD þ naïve B cells and CD10 þ germinal center B cells. 8 In an RT-PCR study, expression of latent genes EBNA1 and LMP was detected in all tonsil B-cell subsets, while growth-promoting EBNA2 expression was limited to the naïve IgD þ B-cell subset. 6 In contrast, in a study of acute IM tonsils, most EBV-positive cells (60-80%) expressed EBNA2, 20-30% expressed LMP1 but not EBNA2, and o10% expressed neither LMP1 nor EBNA2. 9 Most of the EBV-infected cells (82%) detected in this study of human tonsils appear to be small CD20- 10  90  0  ND  11  12  0  6  12  12  28  41  13  10  0  14  14  3  7  13  15  13  0  17  16  0  0  0  17  45  50  112  18  55  44  73  19  50  50  ND  20  21  0  18   Average  23  11  27 ND, not determined.
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positive B cells, some with plasmacytoid features, located primarily in interfollicular regions and intimately associated with crypt epithelium. A little more than half (59%) of the EBER-positive cells were located within the T-cell-rich interfollicular regions of the tonsils, while a significant number (27%) were located within the lymphocyte-rich crypt epithelium. These results are consistent with results of a previous study of acutely infected tonsils from patients with IM in which EBER þ B cells were mainly found in interfollicular areas often adjacent to crypt epithelium. 9 In the present study, 15% of the EBER-positive cells, nearly all of which (92%) stained as weakly CD20 þ B cells, were located within the B-cell-rich germinal centers of secondary follicles. Few follicles contained numerous EBER-positive cells. These results are consistent with previous reports of EBER-positive germinal center B cells in tonsils. 10, 11 It has been suggested that germinal center centroblasts may be a site of EBV persistence. 12, 13 The presence of EBV-positive B cells in germinal centers is reportedly more common in tonsils from areas endemic for EBV þ lymphomas, leading to the suggestion that EBV-infected germinal center B cells may be more prone to malignant transformation, perhaps due to somatic hypermutation. 11 In contrast to the presence of a few EBV-infected B cells in follicular germinal centers, no EBER-positive cells were detected within follicular mantle zones in the present study. Since mantle zone B cells typically express IgD, this result is consistent with previous results in which most EBV-positive B cells in tonsils were shown to be IgD negative. 8 Although the vast majority of the EBV-positive B cells in persistently infected tonsil are latent infected, virus replication presumably from productively infected BZLF1/VCA positive cells, many with plasmacytoid features, has been well documented. 4, [14] [15] [16] In the present study, a significant number (11%) of the EBER-positive tonsil cells had plasmacytoid features and expressed dim to undetectable levels of B-cell antigen CD20, while many expressed EBV BZLF-1 protein characteristic of early lytic activation. These results are in agreement with those in a previous study in which many EBER-positive cells in IM tonsils were CD20-negative, with plasmacytoid features, expressed the EBV immediate-early protein BZLF1, and were positive for the plasma cell antigen detected by monoclonal antibody VS38c.
14 In the present study, expression of the plasma cell antigen CD138 was not detected in the EBER-positive plasmacytoid cells. Reduced expression of CD20 by EBV-infected plasmacytoid B cells is not surprising since both EBV infection and plasmacytoid differentiation are associated with reduced expression of CD20 on B cells. In a study of 37 EBV-transformed B lymphoblastoid cell lines, 11 (30%) of the cell lines were negative for pan-B-cell markers CD19 and CD20. 17 Also, it has been reported that up to 80% of the EBER-positive cells in the peripheral blood exhibit features of plasmacytoid differentiation. 18 In the present study, numerous BZLF1-positive cells were detected within the tonsils, primarily within the lymphocyterich crypt epithelium. This result is consistent with previous reports documenting EBV replication in IM tonsils. 4, 15, 16 Most of these cells appeared to be small-to medium-sized lymphocytes with plasmacytoid features. Given their location just beneath the crypt surface, it seems likely that these cells are the source of most of the infectious virus in saliva. The present results suggest that these small CD20-negative EBER-positive cells are more likely to be plasmacytoid B cells rather than fully mature plasma cells, and that these cells are responsible for nearly all of the EBV production in the tonsil.
In contrast to the large number of CCR3-positive TH2 cells in close contact with EBER-positive cells, relatively few CD8-positive T-cell -EBER þ cell conjugates were identified. This intriguing result suggests that a majority of the EBV-infected cells in tonsils are not targets of T-cell-mediated antiviral cytotoxicity, but instead are surrounded by noncytotoxic Th2 cells that provide a microenvironment conducive to B-cell growth.
EBV infection of epithelial cells occurs in certain pathologic conditions, namely nasopharyngeal carcinoma and oral hairy leukoplakia. [19] [20] [21] [22] Zhang et al 22 analyzed the presence of EBV DNA in nasopharyngeal carcinoma and nasopharyngitis and demonstrated that infection of non-neoplastic nasopharyngeal epithelial cells by EBV may occur in some patients with nasopharyngitis. Furakawa et al 23 in 1990 exposed epithelial cells derived from primary cultures of adenoidal tissue to EBV and was able to detect EBV antigens in these epithelial cells. Also, epithelial cell lines susceptible to EBV infection in vitro have been described. 24 Despite these findings, evidence for the presence of EBV within normal epithelial cells in vivo is conflicting. Some studies have reported the presence of EBV DNA in desquamated squamous epithelial cells and in tonsil epithelium. [25] [26] [27] In contrast, other studies have reported no virus in desquamated epithelial cells or unequivocal evidence of EBV-infected tonsillar epithelial cells by EBER ISH and/or LMP1 immunostaining. 4, 14, 28 The present results, based upon exhaustive histopathologic evaluation of many tonsil sections, provide direct in situ evidence that normal epithelial cells in tonsillar crypts from immunocompetent hosts may rarely be infected by EBV.
Both CD4-and CD8-positive T cells are susceptible to EBV infection in vitro, and there are many examples of EBV-infected T cells in certain pathologic conditions, including NK/T cell lymphoma, hemophagocytic lymphohistiocytosis, and chronic active EBV infection. [29] [30] [31] [32] [33] [34] The complement receptor CR2 (CD21) that serves as the EBV receptor on B cells is expressed by some peripheral blood T cells. 35 However, results of EBER ISH combined with immunohistochemistry with T-cell-specific antibodies on IM tonsils have yielded conflicting results. 4, 14 In the present study, a few EBER-positive CD3-positive tonsillar T cells were identified. Nearly all of the EBER-positive T cells were small cells located within the interfollicular regions. Results of dual EBER/CD4 and EBER/CD8 immunostaining indicate that most of the infected T cells are CD4-positive helper/inducer T cells rather than CD8-positive cytotoxic T cells (Table 2) . Although human monocyte cell lines are susceptible to EBV infection in vitro, 36 EBER positivity could not be demonstrated on dim CD4-positive monocytes in this study.
NK cells are susceptible to EBV infection in vitro. 37 Although NK cells, unlike T cells, do not normally express the CD21 EBV receptor, it has been demonstrated in vitro that NK cells bound to EBVinfected B cells may acquire the receptor via a so-called immunological synapse. 38 Utilizing the NK-cell-specific monoclonal antibody PEN5 39 with EBER ISH, Trempat et al 40 detected a few EBV-positive NK cells in reactive tonsils. In the present study utilizing the anti-PEN5 antibody, we also detected rare EBER-positive NK cells in these tonsils. These rare dual EBER/PEN5-positive cells were small and contracted with apoptotic features. In contrast, EBER-negative PEN5-positive NK cells were noted to be medium-sized lymphocytes with prominent dendritic cytoplasmic projections located just beneath the crypt epithelium (Figure 1i) .
EBV-positive smooth muscle cell tumors have been described in immunocompromised pediatric transplant recipients. [41] [42] [43] Although no EBV-positive endothelial cells or salivary gland cells were detected in the present study, rare BZLF-1-positive mesenchymal spindle cells of undetermined phenotype were identified (Figure 1r) .
The rarity of EBV-infected non-B-cell types in tonsil suggests that under normal circumstances EBV infection of T cells, epithelial cells, and mesenchymal cells is not likely to be biologically relevant. The close physical association of EBERpositive B cells, some of which are lytically active (BZLF1 positive), with EBER-negative crypt epithelial cells and T cells also suggests that transmission of EBV infection from B cells to non-B cells is a rare event. However, these results clearly demonstrate that the virus may rarely be found in non-B-cell types in reactive human tonsils, including T cells, NK cells, epithelial cells, and mesenchymal cells. These results provide a basis for further understanding of how, in some clinical settings characterized by inadequate immune surveillance, rare and unusual EBV-infected non-B-cells may, presumably following genetic mutation, give rise to EBV-positive NK/T cell lymphoma, hemophagocytic syndrome, nasopharyngeal carcinoma, and smooth muscle cell tumors.
